Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ensysce Biosciences (ENSC) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Ensysce Biosciences (ENSC) over the last 6 years, with Q3 2025 value amounting to 0.38.

  • Ensysce Biosciences' Equity Ratio fell 4858.39% to 0.38 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38, marking a year-over-year decrease of 4858.39%. This contributed to the annual value of 0.66 for FY2024, which is 37549.84% up from last year.
  • Latest data reveals that Ensysce Biosciences reported Equity Ratio of 0.38 as of Q3 2025, which was down 4858.39% from 0.61 recorded in Q2 2025.
  • Ensysce Biosciences' 5-year Equity Ratio high stood at 0.74 for Q3 2024, and its period low was 0.77 during Q3 2022.
  • Moreover, its 5-year median value for Equity Ratio was 0.25 (2022), whereas its average is 0.16.
  • In the last 5 years, Ensysce Biosciences' Equity Ratio crashed by 185389.27% in 2022 and then soared by 37549.84% in 2024.
  • Over the past 5 years, Ensysce Biosciences' Equity Ratio (Quarter) stood at 0.5 in 2021, then tumbled by 37.8% to 0.68 in 2022, then soared by 64.88% to 0.24 in 2023, then skyrocketed by 375.5% to 0.66 in 2024, then tumbled by 42.87% to 0.38 in 2025.
  • Its last three reported values are 0.38 in Q3 2025, 0.61 for Q2 2025, and 0.66 during Q1 2025.